triazoles has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 10 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakhshi, S; Caimi, P; Canales, M; Casasnovas, RO; Cavallo, F; Chamoun, K; Choquet, S; Corona, K; De la Cruz, F; Egyed, M; Follows, G; Goy, A; Gurion, R; Hamad, N; Hill, B; Jaeger, U; Kalakonda, N; Kauffman, MG; Ku, M; Kuruvilla, J; Ma, X; Maerevoet, M; Neste, EVD; Offner, F; Samal, P; Sancho, JM; Schuster, M; Shacham, S; Shah, J; Thieblemont, C; Vassilakopoulos, T; Vermaat, JSP; Warzocha, K; Zijlstra, J | 1 |
| Ben Barouch, S; Bhella, S; Crump, M; Kridel, R; Kukreti, V; Kuruvilla, J; Prica, A | 1 |
| Sylvain, C | 1 |
| Baker, S; Bhat, S; Byrd, JC; Canfield, D; Cempre, CB; Fu, Q; Hu, B; Huang, Y; Jaglowski, SM; Lapalombella, R; Lockman, H; Rogers, KA; Ruppert, AS; Shah, H; Stephens, DM; Vadeboncoeur, R; Walker, JS; Woyach, JA | 1 |
| Goldsmith, SR; Liu, L; Shiah, K | 1 |
| Tang, XY; Wang, Y; Xu, RR | 1 |
| Abrisqueta, P; Bobillo, S; Boix, J; Bosch, F; Carabia, J; Castellví, J; Céspedes Torrez, DH; Crespo, M; Escoda, L; Jiménez, I; Martínez-Ricarte, F; Nieto, JC; Pagès, C; Palacio, C; Perla, C; Puigdefàbregas, L; Purroy, N; Seoane, J | 1 |
| Abeykoon, JP; Boughey, JC; Boysen, J; Carr, RM; Couch, FJ; Dasari, S; Feldman, AL; Goetz, MP; Hou, X; Hu, C; Kapoor, P; King, RL; Kumar, S; Manske, MK; Mladek, AC; Molina, JR; Nowakowski, KE; Paludo, J; Parikh, SA; Patnaik, MM; Phillips, JL; Ravindran, A; Robinson, SI; Sarkaria, JN; Stenson, MJ; Wang, L; Weroha, SJ; Witzig, TE; Wu, X; Yu, J | 1 |
| Bader, JC; Li, H; Shacham, S; Shah, J; Tang, S; Wada, R; Xu, H | 1 |
| Aboukameel, A; Azmi, AS; Bhutani, D; Chaker, M; Corona, K; Houde, C; Huddlestun, A; Kauffman, M; Khan, HY; Landesman, Y; Li, Y; Mohammad, RM; Muqbil, I; Neveux, C; Pregja, S; Ramchandren, R; Reichel, K; Seymour, EK; Shacham, S; Shah, J; Sterbis, G; Yang, J; Zonder, JA | 1 |
| Aboukameel, A; Al-Katib, A; Azmi, AS; Kauffman, M; McCauley, D; Mohammad, RM; Shacham, S | 1 |
| Babacan, A; Duru, NK; Ercan, CM; Ergun, A; Keskin, U; Korkmaz, C; Yilmaz, A | 1 |
| Han, X; Shen, Y; Shi, Y; Wang, J; Wang, S; Yao, J; Zhang, N | 1 |
| Assanelli, A; Barbanti, MC; Bernardi, M; Carrabba, M; Ciceri, F; Corti, C; Forcina, A; Giglio, F; Greco, R; Lupo Stranghellini, MT; Marktel, S; Messina, C; Morelli, M; Oltolini, C; Peccatori, J; Piemontese, S; Scarpellini, P; Vago, L | 1 |
| Aboukameel, A; Azmi, AS; Baloglu, E; Bhutani, D; Carlson, R; Elloul, S; Kauffman, M; Mohammad, RM; Muqbil, I; Senapedis, W; Shacham, S; Zonder, J | 1 |
| Bergstresser, P; Chan, J; Dai, W; Dharamsi, JW; Gander, R; Ricotti, C; Soliman, S | 1 |
| Abdulaziz, S; Al Jahdali, H; Baharoon, S | 1 |
| Blin, N; Gaillard, F; Harousseau, JL; Milpied, N; Moreau, P; Morin, O; Morineau, N | 1 |
| Ferhanoglu, B; Mert, A; Sili, U; Yilmaz, M | 1 |
| Afanasjev, S; Antipov, S; Cherdyntseva, N; Schepetkin, I; Zyryanov, B | 1 |
4 review(s) available for triazoles and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
A drug profile on selinexor for the treatment of refractory diffuse large B-cell lymphoma.
Topics: Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Triazoles | 2022 |
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Hydrazines; Lymphoma, Non-Hodgkin; Multiple Myeloma; Triazoles | 2022 |
[The Latest Research Progress of Selinexor in the Treatment of Non-Hodgkin Lymphoma --Review].
Topics: Active Transport, Cell Nucleus; Antineoplastic Combined Chemotherapy Protocols; Humans; Hydrazines; Lymphoma, Non-Hodgkin; Triazoles | 2023 |
Random-start controlled ovarian hyperstimulation with letrozole for fertility preservation in cancer patients: case series and review of literature.
Topics: Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fertility Preservation; Humans; Letrozole; Lymphoma, Non-Hodgkin; Nitriles; Oocyte Retrieval; Ovarian Neoplasms; Ovulation Induction; Triazoles | 2014 |
5 trial(s) available for triazoles and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
Topics: Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Triazoles | 2022 |
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.
Topics: Adenine; Adult; Humans; Hydrazines; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Piperidines; Pyrazoles; Pyrimidines; Triazoles | 2022 |
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Hydrazines; Lymphoma, Non-Hodgkin; Mice; Prednisone; Rituximab; Triazoles; Vincristine | 2021 |
CRM1 as a new therapeutic target for non-Hodgkin lymphoma.
Topics: Acrylamides; Acrylates; Animals; Antineoplastic Agents; Caspases; Cell Cycle Checkpoints; Down-Regulation; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Jurkat Cells; Karyopherins; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Proteins; Proteolysis; Receptors, Cytoplasmic and Nuclear; Thiazoles; Triazoles; Xenograft Model Antitumor Assays | 2015 |
The luminol-amplified chemiluminescence of neutrophils and monocytes in patients with gastric cancer after intraoperative radiotherapy using radiosensitizer sanazole.
Topics: Adenocarcinoma; Aged; Female; Humans; Intraoperative Period; Luminescent Measurements; Luminol; Lymphoma, Non-Hodgkin; Male; Middle Aged; Monocytes; Neutrophil Activation; Neutrophils; Radiation-Sensitizing Agents; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Triazoles | 1999 |
11 other study(ies) available for triazoles and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Long-term follow up of relapsed/refractory non-Hodgkin lymphoma patients treated with single-agent selinexor - a retrospective, single center study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Humans; Hydrazines; Lymphoma, Non-Hodgkin; Retrospective Studies; Triazoles | 2022 |
Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Central Nervous System Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Exportin 1 Protein; Female; Humans; Hydrazines; Karyopherins; Lymphoma, Non-Hodgkin; Macrophages; Mice; Mice, Nude; Piperidines; Receptors, Cytoplasmic and Nuclear; Survival Rate; Triazoles; Tumor Cells, Cultured; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2020 |
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Checkpoints; Choline; DNA Repair; DNA Replication; DNA, Neoplasm; Drug Combinations; Drug Synergism; Exportin 1 Protein; Gene Expression Regulation, Neoplastic; Humans; Hydrazines; Karyopherins; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Proteins; Phthalazines; Piperazines; Random Allocation; Receptors, Cytoplasmic and Nuclear; S Phase Cell Cycle Checkpoints; Salicylates; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Studies as Topic; Female; Humans; Hydrazines; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Treatment Outcome; Triazoles; Young Adult | 2021 |
Selective inhibitors of nuclear export for the treatment of non-Hodgkin's lymphomas.
Topics: Acrylates; Active Transport, Cell Nucleus; Animals; Exportin 1 Protein; Humans; Karyopherins; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mice; Mice, SCID; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Triazoles; Tumor Cells, Cultured; Waldenstrom Macroglobulinemia; Xenograft Model Antitumor Assays | 2013 |
Coadministration of posaconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Remission Induction; Risk; Sirolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Triazoles; Young Adult | 2016 |
Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone.
Topics: Acrylamides; Active Transport, Cell Nucleus; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclophosphamide; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Everolimus; Exportin 1 Protein; Humans; Hydrazines; Karyopherins; Lymphoma, Non-Hodgkin; Mice, Inbred ICR; Mice, SCID; Oxadiazoles; Prednisone; Protein Kinase Inhibitors; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Thiazoles; Time Factors; TOR Serine-Threonine Kinases; Transcription Factor RelA; Triazoles; Tumor Burden; Vincristine; Xenograft Model Antitumor Assays | 2016 |
Cutaneous fusariosis developing in a post-irradiation site.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg Ulcer; Lymphoma, Non-Hodgkin; Opportunistic Infections; Postoperative Complications; Prednisone; Pyrimidines; Radiodermatitis; Radiotherapy; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
Combination antifungal therapy for invasive pulmonary aspergillosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Disseminated mucormycosis associated with invasive pulmonary aspergillosis in a patient treated for post-transplant high-grade non-Hodgkin's lymphoma.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis, Allergic Bronchopulmonary; Caspofungin; Echinocandins; Fatal Outcome; Female; Humans; Kidney Transplantation; Lipopeptides; Lymphoma, Non-Hodgkin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole | 2004 |
Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole.
Topics: Antifungal Agents; Arthritis, Infectious; Candida; Humans; Knee Joint; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mycoses; Pyrimidines; Synovial Fluid; Triazoles; Voriconazole | 2007 |